Unable to load price data. Sorry.

¯\_(ツ)_/¯

Arch Chemicals, Inc. (NYSE:ARJ)

CAPS Rating: No stars

A biocides company providing innovative, chemistry-based solutions to control the growth of harmful microbes. The principal business segments are Treatment Products and Performance Products.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NYSE:ARJ will perform against the market?

Add Stock to CAPS Watchlist

All Players

54 Outperform
6 Underperform
 

All-Star Players

6 Outperform
3 Underperform
 

Wall Street

3 Outperform
1 Underperform
 

Top NYSE:ARJ Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

dreadpal (46.94)
Submitted November 29, 2006

With the rise of dangerous microbes and more importantly, the FEAR of the rise of dangerous microbes, these guys are positioned to make some good strides.

jnthndoug (30.63)
Submitted October 11, 2006

Serious cash working capital growth issues. As it stands the paper the stock is printed on isnt even backed by the assets of the company.

NYSE:ARJ VS S&P 500 (SPY)

Fools bullish on NYSE:ARJ are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ARJ.

Recs

0
Member Avatar adan04 (89.60) Submitted: 6/1/2011 8:41:46 PM : Outperform Start Price: $35.34 NYSE:ARJ Score: -92.21

low P/E cash fountain, on sale

Recs

0
Member Avatar lonelyposeur (< 20) Submitted: 11/24/2010 5:52:22 AM : Outperform Start Price: $34.57 NYSE:ARJ Score: -113.39

War on Microbes!

Recs

0
Member Avatar gea1968 (56.85) Submitted: 6/2/2009 11:27:58 PM : Outperform Start Price: $28.17 NYSE:ARJ Score: -152.57

Fundamentals and momentum; favorable StockScouter rating

Leaderboard

Find the members with the highest scoring picks in ARJ.

Score Leader

Anonimomo

Anonimomo (25.23) Score: +137.78

The Score Leader is the player with the highest score across all their picks in ARJ.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Anonimomo 25.23 5/11/2009 Underperform 3M $24.78 +90.50% +228.28% +137.78 0 Comment
soodsaman 65.83 3/17/2009 Underperform 3M $16.21 +191.14% +298.59% +107.45 0 Comment
supercoffee 97.83 8/1/2008 Underperform 5Y $29.73 +58.76% +141.85% +83.09 0 Comment
TMFNosediveflip 98.50 8/2/2006 Underperform 1Y $26.80 +76.10% +148.96% +72.86 0 Comment
jnthndoug 30.63 10/11/2006 Underperform 3Y $26.99 +74.88% +134.75% +59.87 1 Comment
rossoyoungs < 20 2/26/2007 Outperform 3M $29.17 +61.81% +116.85% -55.04 1 Comment
bpechersky1 52.02 7/23/2007 Outperform NS $32.39 +45.72% +103.47% -57.75 0 Comment
BigWhereItCounts < 20 7/5/2007 Outperform 5Y $31.98 +47.57% +105.78% -58.21 0 Comment
iamlard < 20 12/15/2006 Outperform 3Y $28.93 +63.16% +121.38% -58.22 0 Comment
bpechersky 68.47 7/23/2007 Outperform NS $32.62 +44.71% +103.41% -58.70 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackOppenheimer 22.51 5/29/2009 Outperform NS $25.72 +83.49% +229.31% -145.82 0 Comment
TrackKeyBanc 93.66 12/4/2008 Underperform NS $23.40 -27.59% -16.86% +10.73 3/3/2009 @ $16.94 0 Comment
TrackKeyBanc 93.66 4/29/2008 Underperform NS $36.70 +6.87% +1.76% -5.11 5/7/2008 @ $39.22 0 Comment
TrackWedbush 88.32 1/18/2008 Outperform NS $33.70 -0.26% -9.64% +9.38 7/15/2008 @ $33.61 0 Comment
TrackSoros 84.52 9/30/2007 Outperform NS $42.62 +10.74% +104.58% -93.84 1 Comment
TrackJohnKeeley < 20 9/30/2007 Outperform NS $42.62 +10.74% +104.58% -93.84 1 Comment
TrackBBTCapMkts 33.46 8/8/2007 Outperform NS $40.31 -22.63% -14.01% -8.62 7/31/2008 @ $31.19 0 Comment
TrackOppenheimer 22.51 8/7/2007 Outperform NS $40.36 -10.90% -9.48% -1.43 6/25/2008 @ $35.96 0 Comment
TrackJimCramer 86.29 11/21/2006 Underperform 3W $29.03 +62.60% +124.71% +62.11 0 Comment
TrackWedbush 88.32 11/1/2006 Outperform NS $32.77 +34.93% +12.66% +22.26 10/10/2007 @ $44.22 0 Comment

Advertisement